Compare RLX Technology Inc (RLX) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Sana Biotechnology Inc — how do they compare? RLX Technology Inc trades at $2.03 (market cap $2.52B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: RLX Technology Inc is far larger — about 2.9× Sana Biotechnology Inc's market cap, and RLX Technology Inc pays a 4.85% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| RLX | SANA | |
|---|---|---|
Market Cap | $2.52B | $873.84M |
Sector | Technology | Health |
52-Week High | $2.73 | $5.92 |
52-Week Low | $1.79 | $2.68 |
Enterprise Value | $1.15B | $848.03M |
Dividend Yield | 4.85% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
